SMTL ID : 5vzx.1 (2 other biounits)

Crystal structure of crenezumab Fab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-oligomer

Ligands

11 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 4 residues within 4Å: Chain A: G.105, T.106, T.107, P.148 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.107, A:T.107 SO4.4: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) SO4.5: 3 residues within 4Å: Chain B: P.8, L.9, S.10 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:L.9, B:S.10, B:S.10 SO4.6: 1 residues within 4Å: Chain B: R.59 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:R.59 Salt bridges: B:R.59 SO4.7: 2 residues within 4Å: Chain B: K.108, R.147 2 PLIP interactions: 2 interactions with chain B Salt bridges: B:K.108, B:R.147 SO4.8: 1 residues within 4Å: Chain B: R.216 1 PLIP interactions: 1 interactions with chain B Salt bridges: B:R.216 SO4.9: 4 residues within 4Å: Chain C: G.105, T.106, T.107, P.148 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:T.106, C:T.106, C:T.107 SO4.12: 3 residues within 4Å: Chain D: P.8, L.9, S.10 2 PLIP interactions: 2 interactions with chain D Hydrogen bonds: D:L.9, D:S.10 SO4.13: 1 residues within 4Å: Chain D: R.59 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:R.59, D:R.59 Salt bridges: D:R.59 SO4.14: 2 residues within 4Å: Chain D: K.108, R.147 2 PLIP interactions: 2 interactions with chain D Salt bridges: D:K.108, D:R.147 SO4.15: 1 residues within 4Å: Chain D: R.216 1 PLIP interactions: 1 interactions with chain D Salt bridges: D:R.216

2 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.2: 9 residues within 4Å: Chain A: G.33, S.35, S.98, G.99, D.100 Chain B: H.39, Y.41, S.96, W.101 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:D.100, B:S.96 MES.10: 9 residues within 4Å: Chain C: G.33, S.35, S.98, G.99, D.100 Chain D: H.39, Y.41, S.96, W.101 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:S.35, C:S.35, C:S.35

2 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.3: 5 residues within 4Å: Chain B: Y.31, Y.37, K.55, S.96, T.97 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:Y.37, B:Y.37 Salt bridges: B:K.55 EPE.11: 5 residues within 4Å: Chain D: Y.31, Y.37, K.55, S.96, T.97 4 PLIP interactions: 4 interactions with chain D Hydrogen bonds: D:Y.31, D:Y.31, D:Y.37 Salt bridges: D:K.55

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ultsch, M. et al., Structure of Crenezumab Complex with Abeta Shows Loss of beta-Hairpin. Sci Rep (2016)

Release Date

2017-08-09

Peptides

Crenezumab Fab heavy chain: AC
Crenezumab Fab light chain: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

C
E

B
L

D
I

Crenezumab Fab heavy chain

Crenezumab Fab light chain

Related Entries With Identical Sequence